A new study led by an infectious disease epidemiologist at Tulane University School of Public Health and Tropical Medicine could change the way doctors treat a common sexually transmitted disease.
Oct 5, 2018
2
88
Tulane University researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial published in the latest issue of The Lancet Infectious ...
Sep 13, 2017
0
51
Scientists at the Wellcome Trust Sanger Institute and their collaborators have discovered genetic markers in malaria parasites linked with resistance to the anti-malarial drug piperaquine. Reported in Lancet Infectious Diseases, ...
Nov 3, 2016
0
21
The world should prepare for a "global epidemic" of microcephaly, a condition which restricts head growth in foetuses, as the Zika virus takes root in new countries, researchers said Friday.
Sep 15, 2016
4
64
Parts of Africa and the Asia-Pacific region may be vulnerable to outbreaks of the Zika virus, including some of the world's most populous countries and many with limited resources to identify and respond to the mosquito-borne ...
Sep 1, 2016
0
8
Zika virus has been detected in the amniotic fluid of two pregnant women whose foetuses had been diagnosed with microcephaly, according to a study published today in The Lancet Infectious Diseases. The report suggests that ...
Feb 18, 2016
0
59
Forensic sleuths said Thursday they had found the oldest known egg of the bilharzia parasite, revealing how human advancement enabled a tiny freshwater worm to become a curse for millions.
Jun 19, 2014
0
0
For the first time, scientists have developed a novel and rapid way to test whether the most common and lethal form of malaria is resistant to potent artemisinin drugs.
Sep 10, 2013
0
0
New research published in The Lancet Infectious Diseases provides the first complete viral load profile— a comprehensive clinical description of where and how much of the virus circulates through the body— of a patient ...
Jun 16, 2013
0
0
(Medical Xpress)—The results of a phase 1/2 clinical trial in Europe of an investigational Lyme disease vaccine co-developed by researchers at Stony Brook University, Brookhaven National Laboratory, and at Baxter International ...
May 13, 2013
0
0
